Overview
Keytruda Qlex is approved by the U.S. Food and Drug Administration (FDA) for the treatment of melanoma. It is approved for adults with unresectable or metastatic melanoma and for adults and children 12 years and…
Overview
Keytruda is approved by the U.S. Food and Drug Administration (FDA) for the treatment of individuals with unresectable (inoperable) or metastatic melanoma, as well as for the adjuvant (post-surgical) treatment of…